ePoster

ROLE OF NATURAL ANTIOXIDANTS ON TISSUE TRANSGLUTAMINASE LEVELS IN GLIAL OLFACTORY CELLS EXPOSED TO AMYLOID-Β: INTEGRATED BIOCHEMICAL AND COMPUTATIONAL STUDY

Rosalia Maria Pellitteriand 7 co-authors

National Research Council

FENS Forum 2026 (2026)
Barcelona, Spain
Board PS05-09AM-229

Presentation

Date TBA

Board: PS05-09AM-229

Poster preview

ROLE OF NATURAL ANTIOXIDANTS ON TISSUE TRANSGLUTAMINASE LEVELS IN GLIAL OLFACTORY CELLS EXPOSED TO AMYLOID-Β: INTEGRATED BIOCHEMICAL AND COMPUTATIONAL STUDY poster preview

Event Information

Poster Board

PS05-09AM-229

Abstract

Several findings report the protective effect exerted by nutraceuticals on the health of the nervous system, since many compounds are characterized by antioxidant and anti-inflammatory activities. Alzheimer Disease (AD) is characterized by an aberrant accumulation of amyloid-β (Aβ) responsible of neurotoxicity. Our research focuses on the interaction between some natural antioxidants (berberine and curcumin) and tissue transglutaminase (TG2) levels, in the absence and in the presence of amyloid-β (Aβ) in Olfactory Ensheathing Cells (OECs), a glial cell type of olfactory system. TG2 is an ubiquitarian calcium-dependent protein, involved in AD. Docking studies were performed to ascertain the binding affinity of compounds against the TG2 closed and open forms. In the biological investigation, the effect of berberine and curcumin treatment on TG2 levels in OECs exposed to Aβ was tested. Cell viability, cytoskeleton marker (GFAP, vimentin and nestin) expression, reactive oxygen species (ROS) and apoptotic pathway activation were assessed. Our results demonstrate that pretreatment of OECs with berberine or curcumin counteracted the Aβ-induced upregulation of TG2, restoring its expression to control levels. Furthermore, antioxidant pretreatment reinstated cell viability, normalized the expression of GFAP, vimentin, and nestin, reduced intracellular ROS accumulation, and prevented activation of the apoptotic cascade. The computational data were in quite agreement with biological results. Our findings highlight that berberine and curcumin are able to exert a protective effect against Aβ toxicity in OECs. Therefore, they might represent a promising tool for neural regeneration and for potential therapy slowing or preventing the progression of AD.

Recommended posters

TARGETING ASTROCYTE REACTIVITY TO BETA-AMYLOID PREVENTS OLIGODENDROCYTE MATURATION IMPAIRMENT: NEUROPROTECTIVE POTENTIAL OF CO-ULTRAPEA/LUTEOLIN

Claudia Ciarla, Roberta Facchinetti, Silvia Burla, Marta Valenza, Caterina Scuderi

TARGETING INTRACELLULAR A-ΒETA OLIGOMERS PROMOTES NEUROGENESIS-DEPENDENT RESCUE OF HIPPOCAMPAL FUNCTION AND MEMORY IN AN ALZHEIMER'S DISEASE MOUSE MODEL

Laura Coppola, Raffaella Scardigli, Elena Fiori, Sofia Mancini, Silvia Middei, Federico La Regina, Giovanni Meli, Antonino Cattaneo

SMALL MOLECULES AS A PHARMACOLOGICAL STRATEGY TO PROTECT BDNF RECEPTOR IN ALZHEIMER’S DISEASE

Sara de Oliveira, Lia Barreira-Fernandes, Tiago Costa-Coelho, Mafalda Ferreira-Manso, Ana M. Sebastião, Maria José Diógenes

THE CB2R-OX2R HETEROMER IN MICROGLIA: A PROMISING THERAPEUTIC TARGET IN ALZHEIMER'S DISEASE

Pau Badia Fernàndez, Joan Biel Rebassa Palou, Montserrat Santandreu, Toni Capó, Jaume Lillo, Irene Reyes-Resina, Gemma Navarro

CB1R–OX2R HETEROMER IN ALZHEIMER’S DISEASE: IMPLICATIONS FOR NEURONAL NEUROPROTECTIVE SIGNALING

Antonio Capó Quetglas, Joan Biel Rebassa Palou, Pau Badia, Claudia Garrigós, Marc Sans, Iu Raïch, Jaume Lillo, Irene Reyes-Resina, Gemma Navarro

BENEFICIAL EFFECTS OF DIET SUPPLEMENTATION WITH TRANS-Ε-VINIFERIN IN AN ALZHEIMER’S DISEASE TRANSGENIC MOUSE MODEL

Ambre Touron, Antoine De Mori, Julie Busson, Vincent Thoreau, Sophie Serrière, Sylvie Bodard, Laurent Galineau, Clovis Tauber, Jean-Pierre Remenieras, Jérôme Guillard, Hervé Boutin, Ayache Bouakaz, Guylène Page

Cookies

We use essential cookies to run the site. Analytics cookies are optional and help us improve World Wide. Learn more.